Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 47 | $75,605,481 |
Sells | 92 | $267,926,912 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
24 Nov 2023 16:38 | PMVP | PMV Pharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 22 Nov 2023 | Sale | 87,786 | 2.23 | 195,763 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Dec 2023 | Sale | 9,300 | 60.16 | 559,488 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Dec 2023 | Sale | 3,600 | 60.16 | 216,576 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Dec 2023 | Sale | 14,400 | 60.16 | 866,304 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 13 Dec 2023 | Sale | 14,100 | 58.56 | 825,696 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 13 Dec 2023 | Sale | 36,400 | 58.56 | 2,131,584 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 13 Dec 2023 | Sale | 56,200 | 58.56 | 3,291,072 | I |
15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 57,100 | 56.75 | 3,240,425 | I |
15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 228,500 | 56.75 | 12,967,375 | I |
15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 147,600 | 56.75 | 8,376,300 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 100 | 57.73 | 5,773 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 100 | 57.73 | 5,773 | I |
20 Dec 2023 18:28 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 18 Dec 2023 | Sale | 1,724 | 59.24 | 102,130 | D |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 27 Dec 2023 | Sale | 18,922 | 19.96 | 377,683 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 27 Dec 2023 | Sale | 162,576 | 19.96 | 3,245,017 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 139,166 | 18.32 | 2,549,521 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 1,195,683 | 18.32 | 21,904,913 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 3,128 | 19.82 | 61,997 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 26,872 | 19.82 | 532,603 | I |
25 Jan 2024 16:28 | EWTX | Edgewise Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 23 Jan 2024 | Purchase | 454,545 | 11 | 4,999,995 | I |
26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,041,700 | 2.4 | 2,500,080 | I |
26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 242,200 | 2.4 | 581,280 | I |
26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,841,100 | 2.4 | 4,418,640 | I |
31 Jan 2024 16:12 | AVBP | ArriVent Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 30 Jan 2024 | Purchase | 222,222 | 18 | 3,999,996 | I |
31 Jan 2024 16:12 | AVBP | ArriVent Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 30 Jan 2024 | Purchase | 222,222 | 18 | 3,999,996 | I |
15 Apr 2024 17:25 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 11 Apr 2024 | Sale | 461,899 | 14.49 | 6,692,917 | I |
15 Apr 2024 17:25 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 12 Apr 2024 | Sale | 23,101 | 14.42 | 333,116 | I |
18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 16 Apr 2024 | Sale | 14,069 | 14.01 | 197,107 | I |
18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 17 Apr 2024 | Sale | 300 | 14.15 | 4,245 | I |
18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 18 Apr 2024 | Sale | 2,623 | 14.06 | 36,879 | I |
23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 19 Apr 2024 | Sale | 18,253 | 14.02 | 255,907 | I |
23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 22 Apr 2024 | Sale | 24,609 | 14.05 | 345,756 | I |
23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 23 Apr 2024 | Sale | 21,791 | 14.29 | 311,393 | I |
26 Apr 2024 17:01 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 24 Apr 2024 | Sale | 1,781 | 14.06 | 25,041 | I |
03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 01 May 2024 | Sale | 15,690 | 14.02 | 219,974 | I |
03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 02 May 2024 | Sale | 8,842 | 14.01 | 123,876 | I |
03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 03 May 2024 | Sale | 4,674 | 14.03 | 65,576 | I |
20 May 2024 17:00 | ELVN | Enliven Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 May 2024 | Sale | 1,000,000 | 22.14 | 22,140,000 | I |
20 May 2024 17:00 | ELVN | Enliven Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 May 2024 | Sale | 33,300 | 22.14 | 737,262 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)